Clinical trial
Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis
NCT00470171 · Axcan Pharma, Industry · Completed
Key facts
| NCT number | NCT00470171 |
|---|---|
| Title | Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis |
| Official title | Efficacy and Safety of Ursodesoxycholic Acid in the Management of Non-Alcoholic Steatohepatitis |
| Acronym | URSONASH |
| Lead sponsor | Axcan Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Serum Levels of ALAT Transaminases, Serum Markers for Fibrosis and Hepatic Inflammation |
| Intervention type | Drug |
| Interventions | Ursodesoxycholic acid |
| Enrollment | 98 |
| Start date | Oct 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | May 7, 2007 |
| Last update posted | Feb 3, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: